Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

Expression of herpes simplex protein ICP27 is elevated in AD brain ... In rodent neurons, preventing p-tau formation via the TBK1 inhibitor doubled the amount of ICP27 in these cells. Conversely, ...

However, studies are needed to check if TYK2 inhibitors are able to ... removing amyloid plaques, another protein linked to Alzheimer’s. But targeting tau, the protein at the heart of this ...

Dementia is one of the UK's deadliest and most common neurological diseases, but a 2p drink could help reduce your risk ...

Research has suggested that drinks such as green tea and coffee could reduce someone's risk of dementia, but others have poured cold water on both theories ...

The number of people living with neurological disorders, such as Alzheimer’s disease, epilepsy, multiple sclerosis and ...

Tau is a protein that is found in cells of the central ... Furthest ahead is TauRx, which has a tau aggregation inhibitor called LMTX in a phase 2/3 trial (LUCIDITY) with results due in 2021 ...